Tuesday, September 10, 2024 6:15:26 PM
Ronn Ford signs an agreement, he returned from a trip and in negotiations. Opps thought that was for 2024, that was for 2018
https://www.prweb.com/releases/ronn_motor_group_inc_signs_agreement_with_arbor_lake_capital_a_leading_chinese_m_a_advisory_and_investment_group/prweb15578383.htm
RONN Motor Group, Inc. Signs Agreement With Arbor Lake Capital, A Leading Chinese M&A Advisory and Investment Group
NEWS PROVIDED BY
Ronn Motor Group, Inc.
Jun 28, 2018, 00:15 ET
RONN Motor Group, Inc. Signs Agreement With Arbor Lake Capital, A Leading Chinese M&A Advisory and Investment Group
NEWS PROVIDED BY
Ronn Motor Group, Inc.
Jun 28, 2018, 00:15 ET
SCOTTSDALE, Ariz. (PRWEB) June 27, 2018 -- RONN Motor Group, Inc. (RONN), developers of all-electric hydrogen fuel cell, zero emission, long range transportation platforms, announced today that they have signed an agreement with Arbor Lake Capital to represent RONN on a Joint Venture (JV) and capital raising efforts in China and in the U.S. markets. With a total of $220B invested overseas in 2016, China has become the second largest entity in the world regarding foreign investment. As one of the most experienced boutique cross-border investment banks in China, Arbor Lake Capital is well positioned to serve as the portal for the rest of the world's companies to access Chinese capital and the Chinese market.
“We have just returned from a trip to China with Kevin Hong, Founder and CEO of Arbor Lake Capital,” said Ronn Ford, Chairman and CEO of RONN Motor Group. “We are now actively engaged in MOU/JV negotiations with a major Electric Vehicle (EV) automaker who possesses EV licenses and a state-of-the-art manufacturing capacity of 500,000 EVs annually.
“Ronn’s extensive knowledge and executive team experience in automotive development, manufacturing, and hydrogen technology has accounted for the instant JV offers and MOU terms being discussed within a week of our return from China,” said Kevin Hong, Founder/CEO of Arbor Lake Capital.
Well since Zero Revenue was reported from 2021-2024 what ever happened with the MOU for the China deal?
Recent AIMN News
- Aimwell Bio Highlights Verified Biopharma Intelligence Network Strategy Amid Growing AI Trust Concerns (AIMN) • IH Market News • 05/27/2026 03:17:48 PM
- Why a Verified Biopharma Intelligence Network Is Quietly Becoming the Credential Itself • ACCESS Newswire • 05/27/2026 12:30:00 PM
- The Quiet Restructuring of Healthcare Intelligence: Why the Industry is Moving Toward Verified Professional Networks Over Anonymous AI • ACCESS Newswire • 05/20/2026 12:30:00 PM
- Inside AimwellBio's Federated Health Intelligence Network: Verified Clinical Intelligence Model Gains Attention Among Physicians • ACCESS Newswire • 05/18/2026 12:30:00 PM
- The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For. • ACCESS Newswire • 05/13/2026 12:30:00 PM
- Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones • ACCESS Newswire • 05/11/2026 12:30:00 PM
- While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. • ACCESS Newswire • 05/06/2026 12:30:00 PM
- AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape • ACCESS Newswire • 05/04/2026 12:30:00 PM
- AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings • ACCESS Newswire • 04/27/2026 12:30:00 PM
- Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure • ACCESS Newswire • 04/22/2026 12:30:00 PM
- Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma • ACCESS Newswire • 04/20/2026 12:30:00 PM
- AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio • ACCESS Newswire • 04/15/2026 12:30:00 PM
